QuickLinks
 -- Click here to rapidly navigate through this document
  



 
 

Exhibit 4.13    
  


WARRANT  


THIS WARRANT HAS BEEN ISSUED AND THE SHARES OF COMMON STOCK WHICH MAY BE PURCHASED PURSUANT TO THE EXERCISE OF THE RIGHTS UNDER THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT FOR DISTRIBUTION, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT THERETO UNDER SUCH ACT UNLESS SOLD PURSUANT TO Rule 144 OF SUCH ACT OR UNLESS SUCH SALE, OFFER, PLEDGE, HYPOTHECATION OR
TRANSFER IS OTHERWISE EXEMPT FROM REGISTRATION.


WARRANT TO PURCHASE SHARES OF COMMON STOCK

OF

HEALTHETECH, INC.  


Dated as of December 11, 2002  



	No. CS-9	 	Warrant to Purchase

625,000 Shares of

Common Stock of the Company

(subject to adjustment)





        THIS
CERTIFIES THAT, for value received, American Sales & Merchandising, LLC (the "Holder") is entitled, subject to the terms and
conditions set forth below, to purchase from HealtheTech, Inc., a Delaware corporation (the "Company"), up to six-hundred
twenty-five thousand (625,000) shares of the Company's Common Stock, $0.001 par value per share (the "Shares"), in the amounts and at the
price per share set forth in Section 1 below, subject to the provisions and upon the terms and conditions set forth herein. The term "Warrant" as
used herein shall include this Warrant and any warrants delivered in substitution or exchange therefore as provided herein. 


        1.    Number, Price and Expiration of the Shares.    



        (a)  The
Holder shall have the right to purchase up to a total of two-hundred and twenty-five thousand (225,000) of the Shares (as may be adjusted
pursuant hereto), at an exercise price of $15.00 per share, beginning on the date when the Holder secures a significant purchase order for the purchase of BalanceLog kits in Sam's Club Stores, which
right shall terminate, to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2003. 


        (b)  The
Holder shall have the right to purchase up to a total of two-hundred thousand (200,000) of the Shares (as may be adjusted pursuant hereto), at an
exercise price of $40.00 per share, beginning on the date when the Holder secures a significant purchase order for the purchase of BalanceLog kits in Wal-Mart Stores, which right shall
terminate, to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2005. 



        (c)  The
Holder shall have the right to purchase up to a total of forty thousand (40,000) of the Shares (as may be adjusted pursuant hereto), at an exercise price of $50.00
per share, beginning on the date when the Holder schedules a meeting between the Company and the District Marketing Manager (or equivalent position) of Rite Aid Corporation, which right shall
terminate, to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2005. 



1





 




        (d)  The
Holder shall have the right to purchase up to a total of forty thousand (40,000) of the Shares (as may be adjusted pursuant hereto), at an exercise price of $50.00
per share, beginning on the date when the Holder schedules a meeting between the Company and the District Marketing Manager (or equivalent position) of Costco Wholesale Corporation, which right shall
terminate, to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2005. 


        (e)  The
Holder shall have the right to purchase up to a total of forty thousand (40,000) of the Shares (as may be adjusted pursuant hereto), at an exercise price of $50.00
per share, beginning on the date when the Holder schedules a meeting between the Company and the District Marketing Manager (or equivalent position) of BJ's Wholesale Club, Inc., which right
shall terminate, to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2005. 


        (f)    The
Holder shall have the right to purchase up to a total of forty thousand (40,000) of the Shares (as may be adjusted pursuant hereto), at an exercise price of $50.00
per share, beginning on the date when the Holder schedules a meeting between the Company and the District Marketing Manager (or equivalent position) of MBNA Corporation, which right shall terminate,
to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2005. 



        (g)  The
Holder shall have the right to purchase up to a total of forty thousand (40,000) of the Shares (as may be adjusted pursuant hereto), at an exercise price of $50.00
per share, beginning on the date when the Holder schedules a meeting between the Company and the District Marketing Manager (or equivalent position) of Albertsons, Inc., which right shall
terminate, to the extent not exercised, at 5:00 p.m., Mountain Time, on December 11, 2005. 




        2.    Exercise of Warrant.    



        (a)    Exercise.    The purchase rights represented by this Warrant may be exercised at the election of the Holder, in
whole or in part, in accordance with Section 1 and prior to the expiration of this Warrant, by (i) the tender to the Company at its principal office (or such other office or agency of
the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company) of a notice of exercise in the form attached hereto as  Exhibit A (the "Notice of Exercise"), duly completed and executed on behalf of the Holder,
together with the surrender of this Warrant, and (ii) the payment to the Company of an amount equal to the applicable exercise price(s) multiplied by the number of Shares being purchased by
wire transfer or certified, cashier's or other check acceptable to the Company and payable to the order of the Company. 


        (b)    Stock Certificates.    The rights under this Warrant shall be deemed to have been exercised and the Shares
shall be deemed to have been issued immediately prior to the close of business on the date of its tender for exercise as provided above, and the person entitled to receive the Shares issuable upon
such exercise shall be treated for all purposes as the holder of record of such Shares as of the close of
business on such date. As promptly as reasonably practicable on or after such date, the Company shall direct the Company's transfer agent to issue and deliver to the person or persons entitled to
receive the same a certificate or certificates for that number of shares issuable upon such exercise. In the event that the rights under this Warrant are exercised in part and have not expired, the
Company shall execute and deliver a new Warrant with the same terms and conditions for the number of Shares that remain subject to this Warrant. 


        (c)    Taxes.    In no event shall the Company be required to pay any tax which may be payable in respect of any
transfer involved in the issue and delivery of any certificate in a name other than that of the Holder, and the Company shall not be required to direct the Company's transfer agent to issue or deliver
any such certificate unless and until the person or persons requesting the issue thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the
Company that such tax has been paid. 



2





 





        3.    No Fractional Shares or Scrip.    No fractional shares or scrip representing fractional shares shall be issued
upon the exercise of the rights under this Warrant. In lieu of such fractional share to which the Holder would otherwise be entitled, the Company shall make a cash payment equal to the applicable
exercise price(s) multiplied by such fraction. 


        4.    Replacement of Warrant.    On receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or, in the
case of mutilation, on surrender and cancellation of this Warrant, the Company at the expense of the Holder shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 


        5.    Representations and Warranties of the Holder.    



        (a)    Investment Intent.    The Holder is acquiring the Securities Warrant and the Shares issuable upon exercise of
the Warrant, for investment for his own account, not as a nominee or agent, and not with the view to, or for resale in connection with, any distribution thereof. 


        (b)    Investment Experience.    The Holder has substantial experience in evaluating and investing in private
placement transactions of securities in companies similar to the Company so that he is capable of evaluating the merits and risks of his investment in the Company and has the capacity to protect his
own interests. 


        (c)    Speculative Nature of Investment.    The Holder acknowledges that his investment in the Company is highly
speculative and entails a substantial degree of risk and the Holder is in a position to lose the entire amount of such investment. 


        (d)    Access to Data.    The Holder has had an opportunity to discuss the Company's business, management and
financial affairs with the Company's management. The Holder has also had an opportunity to ask questions of officers of the Company, which questions were answered to his satisfaction. The Holder
understands that such discussions, as well as any information issued by the Company, were intended to describe certain aspects of the Company's business and prospects, but were not necessarily a
thorough or exhaustive description. The Holder acknowledges that any business plans prepared by the Company have been, and continue to be, subject to change and that any projections included in such
business plans or otherwise are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying the projections will not materialize or will vary significantly
from actual results. 


        (e)    Accredited Investor.    The Holder is an "accredited investor" within the meaning of Regulation D,
Rule 501(a), promulgated by the Securities and Exchange Commission under the Securities Act of 1933, as amended (the "Securities Act"). 



        (f)    Residency.    The residency of the Holder is correctly set forth on the signature page hereto. 


        (g)    Restriction on Resales.    The Holder acknowledges that the Warrant and the Shares issuable upon exercise of
the Warrant must be held indefinitely unless subsequently registered under the Securities Act or unless an exemption from such registration is available. The Holder further understands that there is
no assurance that any exemption from registration under the Securities Act will be available or, if available, that such exemption will allow the Holder to dispose of or otherwise transfer any or all
of the Securities under the circumstances, in the amounts or at the times the Holder might propose. 


        (h)    Rule 144.    The Holder is aware of the provisions of Rule 144 promulgated under the Securities
Act which permit limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including among other things, the existence of a public market for the
shares, the availability of certain current public information about the Company, 



3





 





the resale occurring not less than one year after a party has purchased and paid for the security to be sold, the sale being effected through a "broker's transaction" or in transactions directly with
a "market maker" and the number of shares being sold during any three-month period not exceeding specified limitations. The Holder acknowledges that, in the event all of the requirements of
Rule 144 are not met, registration under the Securities Act or an exemption from registration will be required for any disposition of the Securities. The Holder understands that, although
Rule 144 is not exclusive, the Securities and Exchange Commission has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a
registered offering or pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption from registration is available for
such offers or sales and that such persons and the brokers who participate in the transactions do so at their own risk. 


        (i)    Authorization.    



          (i)  The
Holder has all requisite power and authority to execute and deliver this Warrant, to purchase the Shares issuable upon exercise of the rights under this Warrant and
to carry out and perform his obligations under the terms and conditions of this Warrant. All action on the part of the Holder necessary for the authorization, execution, delivery and performance of
this Warrant, and the performance of all of the Holder's obligations under this Warrant, has been taken or will be taken prior to the purchase of this Warrant. 


        (ii)  This
Warrant, when executed and delivered by the Holder, will constitute a valid and legally binding obligation of the Holder, enforceable in accordance with its terms
except: (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors' rights generally, and
(ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity. 


        (iii)  No
consent, approval, authorization, order, filing, registration or qualification of or with any court, governmental authority or third person is required to be
obtained by the Holder in connection with the execution and delivery of this Warrant or the performance of the Holder's obligations hereunder. 




        (j)    Brokers and Finders.    The Holder has not engaged any brokers, finders or agents in connection with this
Warrant, and the Company has not incurred and will not incur, directly or indirectly, as a result of any action taken by the Holder, any liability for brokerage or finders' fees or agents' commissions
or any similar charges in connection with this Warrant. 


        (k)    Investor Counsel.    The Holder acknowledges that he has had the opportunity to review this Warrant and the
exhibits attached hereto and the transactions contemplated by this Warrant with his own legal counsel. The Holder is relying solely on such counsel and not on any statements or representations of the
Company or its agents for legal advice with respect to this investment or the transactions contemplated by this Warrant. 



        (l)    Tax Advisors.    The Holder has reviewed with his own tax advisors the U.S. federal, state, local and foreign
tax consequences of this investment and the transactions contemplated by this Warrant. With respect to such matters, the Holder relies solely on such advisors and not on any statements or
representations of the Company or any of its agents, written or oral. The Holder understands that he (and not the Company) shall be responsible for his own tax liability that may arise as a result of
this investment or the transactions contemplated by this Warrant. 




        6.    Transfer of Warrants; Restrictions on Transfer.    



        (a)    Warrant Register.    The Company shall maintain a register (the "Warrant
Register") containing the name and address of the Holder or Holders. Any Holder of this Warrant or any 



4





 


portion thereof may change its address as shown on the Warrant Register by written notice to the Company requesting such change. Any written notice or written communication required or permitted to
be given to the Holder may be delivered or given by any method provided in Section 11(d) hereof. Until this Warrant is transferred on the Warrant Register, the Company may treat the Holder as
shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding any notice to the contrary. 



        (b)    Warrant Agent.    The Company may, by notice to the Holder, appoint an agent for the purpose of maintaining the
Warrant Register referred to in Section 6(a) above, issuing the Shares or other securities then issuable upon the exercise of the rights under this Warrant, exchanging this Warrant, replacing
this Warrant or any or all of the foregoing. Thereafter, any such registration, issuance, exchange or replacement, as the case may be, shall be made at the office of such agent. 


        (c)    Transferability and Non-negotiability of Warrant.    This Warrant may not be transferred or
assigned in whole or in part without compliance with all applicable federal and state securities laws by the transferor and the transferee. Subject to the provisions of this Warrant with respect to
compliance with the Securities Act and limitations on assignments and transfers, including without limitation compliance with the restrictions on transfer set forth in Section 6(e) hereof,
title to this Warrant may be transferred by endorsement (by the transferor and the transferee executing the assignment form (the "Assignment Form")
attached hereto as Exhibit B) and delivery in the same manner as a negotiable instrument transferable by endorsement and delivery. 



        (d)    Exchange of Warrant upon a Transfer.    On surrender of this Warrant for exchange and a properly endorsed
Assignment Form, and subject to the provisions of this Warrant with respect to compliance with the Securities Act and limitations on assignments and transfers, the Company shall issue to or on the
order of the Holder a new warrant or warrants with the same terms and conditions, in the name of the Holder or such other individual or entity as the Holder (on payment by the Holder of any applicable
transfer taxes) may direct, for the number of shares Shares issuable upon exercise of the rights hereunder and the Company shall register any such transfer upon the Warrant Register. This Warrant and
the Shares issuable upon exercise of the rights under this Warrant must be surrendered to the Company or its warrant or transfer agent, as applicable, as a condition precedent to the sale, pledge,
hypothecation or any other transfer of any interest in any of the securities represented hereby. Upon the transfer of this Warrant pursuant to the terms of this Section 6, the transferee shall
be a "Holder" under the terms hereof. 


        (e)    Restrictions on Transfer of Warrants and Shares; Compliance with Securities Laws.    



          (i)  The
Holder agrees not to make any disposition of all or any portion of the Shares or this Warrant unless and until, and it shall be a condition to the transfer of all
or any portion of the Shares or this Warrant that: (1) there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made
in accordance with such registration statement or (2) (A) the Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement
of the circumstances surrounding the proposed disposition, (B) the transferee shall have agreed in writing to be bound by and subject to the terms, conditions, restrictions, obligations and
other limitations set forth in this Warrant to the same extent as if such transferee were the original Holder hereunder, (C) the transferee shall have confirmed to the satisfaction of the
Company in writing, substantially in the form attached hereto as Exhibit C, that the Shares or the Warrant purchased are being acquired solely
for the transferee's own account and not as a nominee for any other party, for investment and not with a view toward distribution or resale and that the transferee shall have confirmed such other
matters related thereto as may be reasonably requested by the Company, and (D) if requested by the Company, the Holder shall have furnished the Company with an opinion of counsel, 




5





 



reasonably satisfactory to the Company, that such disposition will not require registration of the Warrant or such Shares under the Securities Act. This Warrant or any portion hereof and any Shares
issuable pursuant to the exercise of the rights under this Warrant that are transferred to a transferee shall be subject to the terms, conditions, restrictions, obligations and other limitations set
forth herein. 


        (ii)  Unless
the rights under this Warrant are exercised pursuant to an effective registration statement under the Securities Act that includes the Shares with respect to
which the Warrant was exercised, it shall be a condition to any exercise of the rights under this Warrant that the Holder shall have confirmed to the satisfaction of the Company in writing,
substantially in the form attached hereto as Exhibit C, that the Shares so purchased are being acquired solely for the Holder's own account and
not as a nominee for any other party, for investment and not with a view toward distribution or resale and that the Holder shall have confirmed such other matters related thereto as may be reasonably
requested by the Company. 


        (iii)  This
Warrant and all Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the following form (in addition to any legend
required by state securities laws): 



        "THESE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT FOR DISTRIBUTION, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT THERETO UNDER SUCH ACT UNLESS SOLD PURSUANT TO RULE 144 OF
SUCH ACT OR UNLESS SUCH SALE, OFFER, PLEDGE, HYPOTHECATION OR TRANSFER IS OTHERWISE EXEMPT FROM REGISTRATION." 





        (f)    This
Warrant may not be transferred in part unless such transfer is to a transferee who, pursuant to such transfer, receives the right to purchase at least five thousand
(5,000) Shares hereunder (as adjusted from time to time in accordance with Section 9 hereof). 




        7.    Reservation of Stock.    The Company agrees during the term the rights under this Warrant are exercisable to
reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Shares upon the exercise of the rights under this Warrant and, from time to time,
to use its best efforts to amend its Certificate of Incorporation to provide sufficient reserves of shares of Common Stock issuable upon exercise of the rights under the Warrant. 


        8.    Expiration; Early Termination.    This Warrant shall expire on December 11, 2005, and shall be void
thereafter. Notwithstanding the foregoing, this Warrant shall terminate immediately prior to the voluntary liquidation, dissolution or winding up of the Company. 


        9.    Adjustment Rights.    The number and kind of shares purchasable hereunder and the applicable exercise price(s)
therefore are subject to adjustment from time to time, as follows: 



        (a)    Merger.    If at any time after the date hereof there shall be any reorganization, recapitalization, merger or
consolidation involving the Company in which shares of the Company's stock (other than a reorganization, recapitalization, merger or consolidation or a related combination, reclassification, exchange,
capital reorganization, subdivision of securities or other transaction otherwise provided for herein) are converted into or exchanged for securities, cash or other property, other than as would cause
the expiration of this Warrant, then, as a part of such reorganization, recapitalization, merger or consolidation, lawful provision shall be made so that the Holder shall thereafter be entitled to
receive upon exercise of his rights to purchase the Shares 



6





 


hereunder, the kind and amount of securities, cash or other property of the successor corporation resulting from such reorganization, recapitalization, merger or consolidation, equivalent in value to
that which a holder of the Common Stock deliverable upon exercise of such rights to purchase the Shares hereunder would have been entitled in such reorganization, recapitalization, merger or
consolidation if such rights to purchase the Shares hereunder had been exercised immediately prior to such reorganization, recapitalization, merger or consolidation. In any such case, appropriate
adjustment (as determined in good faith by the Company's Board of Directors) shall be made in the application of the provisions of this Warrant with respect to the rights and interests of the Holder
after such reorganization, recapitalization, merger or consolidation to the end that the provisions of this Warrant (including adjustments of the applicable exercise price(s) and number of shares of
Common Stock purchasable pursuant to the terms and conditions of this Warrant) shall be applicable after the event, as near as reasonably may be, in relation to any shares or other securities
deliverable after that event upon the exercise of the Holder's rights to purchase the Shares pursuant to this Warrant. 


        (b)    Reclassification of Shares.    If the Company at any time after the date hereof shall, by combination,
reclassification, exchange, capital reorganization or subdivision of securities or otherwise (other than a combination, reclassification, exchange, capital reorganization or subdivision of securities
or a related reorganization, recapitalization, merger, consolidation or other transaction otherwise provided for herein), change any of the securities as to which purchase rights under this Warrant
exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter provide for the right or rights to acquire such number and kind of securities as
would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Warrant immediately prior to such combination,
reclassification, exchange, capital reorganization, subdivision or other change. In any such case, appropriate adjustment (as determined in good faith by the Company's Board of Directors) shall be
made in the application of the provisions of this Warrant with respect to the rights and interests of the Holder after such combination, reclassification, capital reorganization, exchange, subdivision
or change to the end that the provisions of this Warrant (including adjustments of the applicable exercise price(s) and number of shares of Common Stock purchasable pursuant to the terms and
conditions of this Warrant) shall be applicable after the event, as near as reasonably may be, in relation to any shares or other securities deliverable after that event upon the exercise of the
Holder's rights to purchase the Shares pursuant to this Warrant. 


        (c)    Subdivisions and Combinations.    In the event that the Company shall at any time subdivide (by stock split, by
payment of a stock dividend or otherwise) the outstanding shares of Common Stock, the number of Shares issuable upon exercise of the rights under this Warrant immediately prior to such subdivision
shall, concurrently with the effectiveness of such subdivision, be proportionately increased, and the applicable exercise price(s) shall be proportionately decreased, and in the event that the Company
shall at any time combine (by reclassification or otherwise) the outstanding shares of Common Stock into a lesser number of shares of Common Stock, the number of Shares issuable upon exercise of the
rights under this Warrant immediately prior to such combination shall, concurrently with the effectiveness of such combination, be proportionately decreased, and the applicable exercise price(s) shall
be proportionately increased. 


        (d)    Notice of Adjustments.    Upon any adjustment of any of the exercise prices or any increase or decrease in the
number of Shares purchasable upon the exercise of the rights under this Warrant in accordance with this Section 9, then, and in each such case, the Company, within thirty (30) days
thereafter, shall promptly give notice thereof, to the Holder at the address of such Holder as shown on the Warrant Register of the Company, delivered by any method provided in Section 11(d)
hereof, which notice shall state the event giving rise to the adjustment, the exercise 



7





 





price(s) as adjusted and, if applicable, the increased or decreased number of Shares purchasable upon the exercise of the rights under this Warrant, setting forth in reasonable detail the method of
calculation of each. 


        (e)    Other Notices.    In the event that the Company shall authorize: (1) the issuance of any dividend or
other distribution on the Common Stock (other than: (i) repurchases of Common Stock issued to or held by employees, officers, directors or consultants of the Company or its subsidiaries upon
termination of their employment or services pursuant to agreements providing for the right of said repurchase; (ii) repurchases of Common Stock issued to or held by employees, officers,
directors or consultants of the Company or its subsidiaries pursuant to rights of first refusal contained in
agreements providing for such right; or (iii) repurchases of capital stock of the Company in connection with the settlement of disputes with any stockholder), whether in cash, property, stock
or other securities; (2) the voluntary liquidation, dissolution or winding up of the Company; or (3) any transaction resulting in the expiration of this Warrant; then, in each such case,
the Company shall give written notice thereof to the Holder at the address of such Holder as shown on the Warrant Register of the Company, delivered by any method provided in Section 11(d)
hereof, at least five (5) days prior to the effective date of such event. The notice provisions set forth in this section may be shortened or waived prospectively or retrospectively by the vote
or written consent of the holders of a majority of the Shares issuable upon exercise of the rights under this Warrant. 




        10.    No Rights as Stockholder.    Nothing contained herein shall entitle the Holder to any rights as a stockholder
of the Company or to be deemed the holder of Common Stock or any other securities that may at any time be issuable on the exercise of the rights hereunder for any purpose nor shall anything contained
herein be construed to confer upon the Holder, as such, any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold
consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value or change of stock to no par value, consolidation, merger,
conveyance or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise or any other rights of a stockholder of the Company until the rights under the
Warrant shall have been exercised and the Shares purchasable upon exercise of the rights hereunder shall have become deliverable as provided herein. 


        11.    Miscellaneous.     



        (a)    Effective Date.    The provisions of this Warrant shall be construed and shall be given effect in all respects
as if it had been executed and delivered by the Company on the date hereof. 


        (b)    Waiver and Amendment.    Any provision of this Warrant may be amended, waived or modified only upon the written
consent of the Company and the Holder. 


        (c)    Successors and Assigns.    Except as provided in Section 6, this Warrant, and any and all rights, duties
and obligations hereunder, shall not be assigned, transferred, delegated or sublicensed by any party hereto without the prior written consent of the other party. Any attempt by a party without such
permission to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Warrant shall be void. Subject to the foregoing and except as otherwise provided herein,
the provisions of this Warrant shall inure to the benefit of, and be binding upon, the successors and assigns of the parties. 


        (d)    Notices.    All notices and other communications provided for hereunder shall be in writing and delivered,
mailed or telecopied. Notices and other communications to the Holder shall be directed to the Holder at his address as shown on the Warrant Register maintained by the Company; and notices
and other communications to the Company shall be directed to the Company at its address as shown on the signature page hereto (any notice or other communication 



8





 





sent to the Company should be directed to the attention of the President or Chief Financial Officer of the Company); or, as to each party, at such other address as shall be designated by such party
in a written notice to the other party pursuant hereto. Any such notice or other communication shall be deemed to have been duly given (i) when sent by Federal Express or other overnight
delivery service of recognized standing, on the business day following deposit with such service; (ii) when mailed by registered or certified mail, first class postage prepaid and addressed as
aforesaid through the United States Postal Service, upon receipt; (iii) when delivered by hand, upon delivery; and (iv) when telecopied, upon confirmation of receipt. Any party hereto
may by notice so given change its address for future notice hereunder. 


        (e)    Governing Law.    This Warrant and all actions arising out of or in connection with this Warrant shall be
governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law provisions of the State of Delaware, or of any other state. 



        (f)    Further Assurances.    Each party hereto agrees to execute and deliver, by the proper exercise of its
corporate, limited liability company, partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as may be reasonably necessary to more
fully effectuate this Warrant. 


        (g)    Entire Agreement.    Except as expressly set forth herein, this Warrant (including the exhibits attached
hereto) constitutes the entire agreement and understanding of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings relating to such
subject matter. 


        (h)    WAIVER OF JURY TRIAL.    EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AND
ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS WARRANT OR THE ACTIONS OF ANY PARTY HERETO IN NEGOTIATION, ADMINISTRATION,
PERFORMANCE OR ENFORCEMENT HEREOF. 


        (i)    Counterparts.    This Warrant may be executed in one or more counterparts, all of which shall be considered one
and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not
sign the same counterpart. 


        (j)    Titles and Subtitles.    The titles and subtitles used in this Warrant are used for convenience only and are
not to be considered in construing or interpreting this Warrant. All references in this Warrant to
sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto. 



9





 

        IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed as of the date first above written. 



	 	 	HEALTHETECH, INC.
	

 	
 	

By:	
 	

/s/ JAMES R. MAULT
 James R. Mault, M.D.
 Chairman and Chief Executive Officer
	 	 	 	 	Address:	 	523 Park Point Drive, 3rd Floor

Golden, Colorado 80401





        In
connection with the execution of this Warrant, the undersigned Holder acknowledges and agrees to the Representations and Warranties of the Holder contained in Section 5 hereof: 



	

 	
 	

By:	
 	

/s/ MICHAEL A. LIBERTY

	 	 	 	 	Name:	 	Michael A. Liberty
	 	 	 	 	Title:	 	Manager
	 	 	 	 	Address:	 	443 Congress St.

Portland, ME 04101




(Signature Page to Warrant to Purchase Shares of Common Stock of HealtheTech, Inc.)


10







 
 

EXHIBIT A    
    
    NOTICE OF EXERCISE    
  



	TO:	 	HEALTHETECH, INC.
	

ATTN:	
 	

PRESIDENT





        (1)  The
undersigned Holder hereby elects to purchase            shares of the Common Stock of HEALTHETECH, INC., pursuant to the terms of the attached Warrant to
Purchase Shares of Common Stock, dated as of December 11, 2002 (the "Warrant"), between HEALTHETECH, INC. and the Holder, and tenders
herewith payment of the purchase price for such shares in full, together with all applicable transfer taxes, if any. 



        (2)  Please
issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name as is specified below: 



	 	 	
 Name
	

 	
 	

 Address





        (3)  Please
issue a new Warrant for the unexercised portion of the attached Warrant in the name of the undersigned or in such other name as is specified below: 



	 	 	
 Name
	

 	
 	

 Address





        (4)  The
undersigned hereby represents and warrants that the aforesaid shares of Common Stock are being acquired for investment, solely for the account of the undersigned and
not as a nominee for any other person and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned has no present intention of distributing or reselling
such shares except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any applicable state securities laws, and all representations and warranties of
the undersigned set forth in Section 5 and Section 6(e) of the attached Warrant are true
and correct as of the date hereof. In support thereof, the undersigned agrees to execute an Investment Representation Statement in a form substantially similar to the form attached to the Warrant as  Exhibit C. 



	
 Date	 	
 Signature
	

 	
 	

 Name
	

 	
 	

 Title and Name of Entity (if signing on

behalf of an entity)









 
 

EXHIBIT B    
    
    ASSIGNMENT FORM    
  



	ASSIGNOR:	 	        

	COMPANY:	 	HEALTHETECH, INC.
	WARRANT:	 	THE WARRANT (THE "WARRANT") TO PURCHASE SHARES OF COMMON STOCK ISSUED ON DECEMBER 11, 2002 (THE "WARRANT")
	DATE:	 	        






        FOR
VALUE RECEIVED, the undersigned registered Holder of the Warrant ("Assignor") hereby sells, assigns and transfers unto the Assignee
named below all of the rights of the undersigned under the within Warrant, with respect to the number of shares of Common Stock set forth below: 



	Name of Assignee
	 	Address
	 	Number of Shares
	 	Exercise Period

	 	 	 	 	 	 	 
	 	 	 	 	 	 	 





and
does irrevocably constitute and appoint                        as attorney to make such transfer on the books of HEALTHETECH,
 INC., maintained for the purpose, with full power of substitution in
the premises. 


        Each
of the Assignor and Assignee also represent and warrant that, by assignment hereof, the Assignee acknowledges that the Warrant and the shares of stock to be issued upon exercise of
the rights thereunder are being acquired for investment and that the Assignee will not offer, sell or otherwise dispose of the Warrant or any shares of stock to be issued upon exercise of the rights
thereunder except under circumstances which will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. Further, the Assignee has acknowledged that upon
exercise of any rights under the Warrant, the Assignee shall, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the shares of stock so purchased are being
acquired for investment and not with a view toward distribution or resale. In support thereof, the undersigned Assignee agrees to execute an Investment Representation Statement in a form substantially
similar to the form attached to the Warrant as Exhibit C in connection with this assignment and any exercise of the rights under the Warrant. 



	ASSIGNOR:	 	ASSIGNEE:
	

By:	
 	

        
	
 	

By:	
 	

        

	 	 	Name:

Title:	 	 	 	 	 	Name:

Title:	 	 
	

 	
 	

Address:	
 	

        
	
 	

 	
 	

Address:	
 	

        

	

 	
 	

 	
 	

        
	
 	

 	
 	

 	
 	

        









  



 
 

EXHIBIT C    
    
    INVESTMENT REPRESENTATION STATEMENT    
  



	HOLDER:	 	        

	COMPANY:	 	HEALTHETECH, INC.
	SECURITIES:	 	THE WARRANT (THE "WARRANT") TO PURCHASE SHARES OF COMMON STOCK ISSUED ON DECEMBER 11, 2002 AND THE COMMON STOCK ISSUED OR ISSUABLE UPON EXERCISE THEREOF
	AMOUNT:	 	                         SHARES
	DATE:	 	        






        In
connection with the purchase of the above-listed Securities, the undersigned Holder represents and warrants to, and agrees with, the Company as follows: 


        1.    Investment Intent.    The Holder is acquiring the Securities for investment for his own account, not as a
nominee or agent, and not with the view to, or for resale in connection with, any distribution thereof. 


        2.    Investment Experience.    The Holder has substantial experience in evaluating and investing in private placement
transactions of securities in companies similar to the Company so that he is capable of
evaluating the merits and risks of his investment in the Company and has the capacity to protect his own interests. 


        3.    Speculative Nature of Investment.    The Holder acknowledges that his investment in the Company is highly
speculative and entails a substantial degree of risk and the Holder is in a position to lose the entire amount of such investment. 



        4.    Access to Data.    The Holder has had an opportunity to discuss the Company's business, management and financial
affairs with the Company's management. The Holder has also had an opportunity to ask questions of officers of the Company, which questions were answered to its satisfaction. The Holder understands
that such discussions, as well as any information issued by the Company, were intended to describe certain aspects of the Company's business and prospects, but were not necessarily a thorough or
exhaustive description. The Holder acknowledges that any business plans prepared by the Company have been, and continue to be, subject to change and that any projections included in such business
plans or otherwise are necessarily speculative in nature, and he can be expected that some or all of the assumptions underlying the projections will not materialize or will vary significantly from
actual results. 


        5.    Accredited Investor.    The Holder is an "accredited investor" within the meaning of Regulation D,
Rule 501(a), promulgated by the Securities and Exchange Commission under the Securities Act of 1933, as amended (the "Securities Act"). 


        6.    Residency.    The residency of the Holder (or, in the case of a partnership or corporation, such entity's
principal place of business) is correctly set forth on the signature page hereto. 


        7.    Restriction on Resales.    The Holder acknowledges that the Securities must be held indefinitely unless
subsequently registered under the Securities Act or unless an exemption from such registration is available. The Holder further understands that there is no assurance that any exemption from
registration under the Securities Act will be available or, if available, that such exemption will allow the Holder to dispose of or otherwise transfer any or all of the Securities under the
circumstances, in the amounts or at the times the Holder might propose. 


        8.    Rule 144.    The Holder is aware of the provisions of Rule 144 promulgated under the Securities
Act which permit limited resale of shares purchased in a private placement subject to the 


Exhibit C - Page 1





 




satisfaction of certain conditions, including among other things, the existence of a public market for the shares, the availability of certain current public information about the Company, the resale
occurring not less than one year after a party has purchased and paid for the security to be sold, the sale being effected through a "broker's transaction" or in transactions directly with a "market
maker" and the number of shares being sold during any three-month period not exceeding specified limitations. The Holder acknowledges that, in the event all of the requirements of Rule 144 are
not met, registration
under the Securities Act or an exemption from registration will be required for any disposition of the Securities. The Holder understands that, although Rule 144 is not exclusive, the
Securities and Exchange Commission has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a registered offering or pursuant to
Rule 144 will have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales and that such persons and the brokers who participate
in the transactions do so at their own risk. 


        9.    Authorization.    The Holder has all requisite power and authority to execute and deliver the Warrant, to
purchase the Securities and to carry out and perform its obligations under the terms of the Warrant. All action on the part of the Holder necessary for the authorization, execution, delivery and
performance of the Warrant, and the performance of all of the Holder's obligations under the Warrant, has been taken or will be taken prior to the purchase of the Warrant. 



        (b)  The
Warrant, when executed and delivered by the Holder, will constitute a valid and legally binding obligation of the Holder, enforceable in accordance with its terms
except: (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors' rights generally, and
(ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity. 



        (c)  No
consent, approval, authorization, order, filing, registration or qualification of or with any court, governmental authority or third person is required to be obtained
by the Holder in connection with the execution and delivery of the Warrant or the performance of the Holder's obligations hereunder. 




        10.    Brokers or Finders.    The Holder has not engaged any brokers, finders or agents, and the Company has not
incurred and will not incur, directly or indirectly, as a result of any action taken by the Holder, any liability for brokerage or finders' fees or agents' commissions or any similar charges in
connection with the Warrant. 


        11.    Investor Counsel.    The Holder acknowledges that he has had the opportunity to review the Warrant and the
exhibits attached thereto and the transactions contemplated by the Warrant with his own legal counsel. The Holder is relying solely on such counsel and not on any statements or representations of the
Company or its agents for legal advice with respect to this investment or the transactions contemplated by the Warrant. 


        12.    Tax Advisors.    The Holder has reviewed with his own tax advisors the U.S. federal, state, local and foreign
tax consequences of this investment and the transactions contemplated by the Warrant. With respect to such matters, the Holder relies solely on such advisors and not on any statements or
representations of the Company or any of its agents, written or oral. The Holder understands that it (and not the Company) shall be responsible for his own tax liability that may arise as a result of
this investment or the transactions contemplated by the Warrant. 


        13.    Further Limitations on Disposition.    Without in any way limiting the representations and warranties set forth
above, the Holder agrees not to make any disposition of all or any portion of the Securities unless and until, and it shall be a condition to the transfer of all or any portion of the Securities that:
(1) there is then in effect a registration statement under the Securities Act covering 


Exhibit C - Page 2





 


such proposed disposition and such disposition is made in accordance with such registration statement or (2) (A) the Holder shall have notified the Company of the proposed disposition and
shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, (B) the transferee shall have agreed in writing to be bound by and subject
to the terms, conditions, restrictions, obligations and other limitations set forth in the Warrant to the same extent as if such transferee were the original Holder thereunder, (C) the
transferee shall have confirmed to the satisfaction of the Company in writing, substantially in the form attached to the Warrant as Exhibit C,
that the Securities are being acquired solely for the transferee's own account and not as a nominee for any other party, for investment and not with a view toward distribution or resale and that the
transferee shall have confirmed such other matters related thereto as may be reasonably requested by the Company, and (D) if requested by the Company, the Holder shall have furnished the
Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of the Securities under the Securities Act. The Securities that are
transferred to a transferee shall be subject to the terms, conditions, restrictions, obligations and other limitations set forth herein and therein. 


(The remainder of this page is intentionally left blank.)


Exhibit C - Page 3








        IN WITNESS WHEREOF, the Holder has caused this Investment Representation Statement to be duly executed and delivered by its proper and duly authorized officers as of the date and year
first written above. 



	 	 	HOLDER:
	

 	
 	

By:	

    

	

 	
 	

Name:	

    

	

 	
 	

Title:	

    

	

 	
 	

Address:
	

 	
 	


	

 	
 	


	

 	
 	






(Signature page to the Investment Representation Statement)





AMENDMENT TO WARRANT NO. CS-9  


        This AMENDMENT TO WARRANT NO. CS-9 (this "Amendment") is made and effective as of December 11,
2002 and amends to the extent set forth herein that certain Warrant to Purchase Shares of Common Stock of HealtheTech, Inc. dated as of December 11, 2002, No. CS-9 (the
"Warrant") issued to the Holder by the Company (each as defined in the Warrant). Capitalized terms used herein and not otherwise defined shall have the
meanings ascribed in the Warrant. In consideration of the mutual
covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Holder mutually agree as follows: 


	1.
	Section 6(e)(i) of
the Warrant shall be amended by the addition of the following provision thereto: 



"Notwithstanding
the foregoing, no such opinion of counsel shall be necessary for a transfer without consideration by a Holder which is a partnership to a partner of such partnership, so long as such
transfer is made pursuant to the terms of the partnership agreement, or to the transfer by gift, will or intestate succession by the Holder to his or her spouse or ancestors or any trust for the
benefit of any of the foregoing if the transferee agrees in writing to be subject to the terms hereof to the same extent as if he/she were an original Holder hereunder. Notwithstanding the foregoing,
such Shares may be offered, sold or otherwise disposed of in accordance with Rule 144." 



	2.
	Section 11
of the Warrant shall be amended by the addition of the following provision thereto: 



"(k)    Registration Rights.    The Shares issued upon exercise of this Warrant shall have certain registration rights as set forth
in Exhibit D. Such rights shall survive any valid transfer of the Shares or the Warrant and inure to the benefit of the Holder thereof." 



	3.
	Annex I to this Amendment shall be attached to the Warrant as Exhibit D thereto and incorporated therein in its entirety. 


[Signature page follows]






Each
of the Company and Holder have caused this Amendment to Warrant No. CS-9 to be executed and delivered as of the day and year first above written. 



	 	 	HEALTHETECH, INC.
	

 	
 	

/s/ James. R. Mault
	

 	
 	

By:	
 	

JAMES R. MAULT, M.D.
 Chairman and CEO
	

 	
 	
HOLDER
	

 	
 	

/s/ Michael A. Liberty
	

 	
 	

By:	
 	

MICHAEL A. LIBERTY
 Manager











 
 

ANNEX I


 
 

EXHIBIT D
  REGISTRATION RIGHTS    
  


        1.    Company Registration.    



        (a)    Registration.    If at any time or from time to time, the Company shall determine to register any of its
securities for its own account, other than (i) a registration on Form S-8 (or a similar or successor form) relating solely to employee stock option, stock purchase or other
benefit plans, or (ii) a registration on Form S-4 (or similar or successor form) relating solely to a Securities and Exchange Commission (the "Commission") Rule 145
transaction, the Company will: 



          (i)  promptly
give to the Holder written notice thereof; and 


        (ii)  offer
to include in such registration (and any related qualification under blue sky laws or other compliance), and in any underwriting involved therein, all the Shares
specified in a written request or requests, made within 15 days after mailing of written notice by the Company. 




        (b)    Underwriting.    If the registration of which the Company gives notice is for a registered public offering
involving an underwriting, the Company shall so advise the Holder as a part of the written notice given pursuant to Section 1(a)(i) above. In such event the right of the Holder to registration
pursuant to this section shall be conditioned upon such Holder's participation in such underwriting and the inclusion of such Shares in the underwriting to the extent provided herein. 



        The
Holder proposing to distribute the Shares through such underwriting shall (together with the Company and, if applicable, any other holders distributing their securities through such
underwriting) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any other provision of this
section, if the managing underwriter determines that marketing factors require a limitation of the number of shares to be underwritten, the underwriter may limit the number or exclude all of the
Shares to be included in the registration and underwriting. The number of securities includable by the Holder may, in the
discretion of the underwriters, be rounded to the nearest one hundred shares. No securities excluded from the underwriting by reason of the underwriter's marketing limitation shall be included in such
registration. If some but not all of the Shares are to be excluded from a registration, the Shares to be included in the registration shall be allocated on a pro rata basis based on the total number
of shares of all securities being included in such registration; provided that no Registrable Securities, as that term is defined in that Sixth Amended and Restated Investor Rights Agreement made as
of June 21, 2001 (the "IRA") by and among the Company, the New Series C Investors (as defined in the IRA), the Prior Series C Investors (as defined in the IRA), the Founders (as
defined in the IRA), the Baby-C Holders (as defined in the IRA) and the Series A Investors and Series B Investors (as defined in the IRA), shall be excluded from any Company
Registration underwriting until all shares of Shares have been excluded from such underwriting. 


        If
the Holder disapproves of the terms of any such underwriting, the Holder may elect to withdraw there from by written notice to the Company and the underwriter. Any securities excluded
or withdrawn from such underwriting shall be withdrawn from such registration. 



        If
the underwriter has not limited the number of such shares to be underwritten for the Company's account and the account of the Holder, the Company may then include securities for the
account of employees, officers, directors and consultants. 




        (c)    Right to Terminate Registration.    The Company shall have the right to terminate or withdraw any registration
initiated by it under this Section 1 prior to the effectiveness of such registration whether or not the Holder has elected to include the Shares in such registration. 







        2.    Registration Procedures.    In the case of each registration, qualification or compliance effected by the
Company pursuant to this section, the Company will keep the Holder advised in writing as to the initiation of each registration, qualification and compliance and as to the completion thereof. At its
expense the Company will: 



        (a)  Prepare
and file with the SEC a registration statement with respect to such securities and use reasonable efforts to cause such registration statement to become and
remain effective for at least 180 days or until the Holder have completed the distribution described in the registration statement relating thereto, whichever first occurs; and 


        (b)  Furnish
to the Holder participating in the registration such number of prospectuses, preliminary prospectuses, final prospectuses and such other documents as the Holder
may reasonably request in order to facilitate the public sale or other disposition of the Shares being sold by the Holder. 




        3.    Information by Holder.    If any of the Shares are included in any registration, the Holder shall furnish to the
Company such information regarding the Holder and the distribution proposed by the Holder as the Company may reasonably request in writing and as shall be required in connection with any registration,
qualification or compliance referred to in this section. 


        4.    Assignment of Registration Rights.    The rights to cause the Company to register securities and related rights
granted the Holder under this section may not be assigned except (i) to a successor entity to the Holder pursuant to a reorganization or recapitalization of such Holder or (ii) to the
constituent partners or affiliates of the Holder; provided, that the Company receives notice within a reasonable time after such assignment and the transferee agrees in writing to be bound by the
provisions hereof. 


        5.    Termination of Registration Rights.    The registration rights granted pursuant to this section shall terminate
upon the occurrence of any of the following: 



        (a)  Following
the Company's first registered offering to the public, of its Common Stock and registration of its Common Stock under the Exchange Act, at such time as all
Shares held by the Holder can be sold within a given three (3) month period without compliance with the registration requirements of the Securities Act pursuant to Rule 144 (or its
successor provision); or 


        (b)  Three
years from the effective date of the Company's first registered offering to the public. 














QuickLinks



Exhibit 4.13



EXHIBIT A NOTICE OF EXERCISE


EXHIBIT B ASSIGNMENT FORM


EXHIBIT C INVESTMENT REPRESENTATION STATEMENT



ANNEX I


EXHIBIT D REGISTRATION RIGHTS